XML 51 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Short-term Investments and Financial Instruments
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:
 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
21,439

 
$
21,439

 
$

 
$

Forward foreign currency exchange contracts
35

 

 
35

 

Interest rate swap agreement
21

 

 
21

 

Total assets at fair value
$
21,495

 
$
21,439

 
$
56

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
21,074

 
$
21,074

 
$

 
$

Forward foreign currency exchange contracts
131

 

 
131

 

Liability for contingent consideration, current and non-current
114,036

 

 

 
114,036

Total liabilities at fair value
$
135,241

 
$
21,074

 
$
131

 
$
114,036



The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2016:

 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
17,893

 
$
17,893

 
$

 
$

Forward foreign currency exchange contracts
33

 

 
33

 

Interest rate swap agreement

 

 

 

Total assets at fair value
$
17,926

 
$
17,893

 
$
33

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
17,893

 
$
17,893

 
$

 
$

Forward foreign currency exchange contracts
551

 

 
551

 

Liability for contingent consideration, current and non-current
24,652

 

 

 
24,652

Total liabilities at fair value
$
43,096

 
$
17,893

 
$
551

 
$
24,652

Fair Value, Business Acquisition, Liability for Contingent Consideration
The table below provides a summary of the changes in fair value of the Company’s contingent considerations for the Imago, Network1 and Intelisys earnouts, which is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the fiscal year ended June 30, 2017:
 
Contingent Consideration for the Fiscal Year Ended 

 
June 30, 2017
 
Worldwide Barcode, Networking & Security Segment
 
Worldwide Communications & Services Segment
 
Total
 
(in thousands)
Fair value at beginning of period
$

 
$
24,652

 
$
24,652

Issuance of contingent consideration

 
95,000

 
95,000

Payments

 
(10,241
)
 
(10,241
)
Change in fair value

 
5,211

 
5,211

Fluctuation due to foreign currency exchange

 
(586
)
 
(586
)
Fair value at end of period
$

 
$
114,036

 
$
114,036



The table below provides a summary of the changes in fair value of the Company’s contingent considerations for the CDC, Imago and Network1 earnouts, which is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the fiscal year ended June 30, 2016:
 
Contingent Consideration for the Fiscal Year Ended 

 
June 30, 2016
 
Worldwide Barcode, Networking & Security Segment
 
Worldwide Communications & Services Segment
 
Total
 
(in thousands)
Fair value at beginning of period
$
5,109

 
$
28,851

 
$
33,960

Payments
(4,453
)
 
(4,153
)
 
(8,606
)
Change in fair value
181

 
1,113

 
1,294

Fluctuation due to foreign currency exchange
(837
)
 
(1,159
)
 
(1,996
)
Fair value at end of period
$

 
$
24,652

 
$
24,652

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for our contingent consideration liabilities as of June 30, 2017 and 2016 were as follows.

Reporting Period
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted Average Rates
June 30, 2017
 
Discounted cash flow
 
Weighted average cost of capital
 
14.2
%
 
 
 
 
Adjusted EBITDA growth rate
 
17.0
%
 
 
 
 
 
 
 
June 30, 2016
 
Discounted cash flow
 
Weighted average cost of capital
 
17.1
%
 
 
 
 
Adjusted EBITDA growth rate
 
40.7
%